Melinda Hamm, MA, CCC-SLP | |
261 College Hill Rd, Waco, KY 40385-9715 | |
(859) 369-7528 | |
Not Available |
Full Name | Melinda Hamm |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 261 College Hill Rd, Waco, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932641263 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | SLPLPA00220916 (Kentucky) | Primary |
Mailing Address | Practice Location Address |
---|---|
Melinda Hamm, MA, CCC-SLP 261 College Hill Rd, Waco, KY 40385-9715 Ph: (859) 369-7528 | Melinda Hamm, MA, CCC-SLP 261 College Hill Rd, Waco, KY 40385-9715 Ph: (859) 369-7528 |
News Archive
Health care could be the next Michigan industry to take a tumble, as hospitals anticipate caring for more uninsured patients in the wake of General Motor's bankruptcy and cuts to the state Medicaid program, the Detroit Free Press reports.
The 57 million Americans currently living with "pre-diabetes" could benefit from a group weight loss program, like Weight Watchers, according to a new study published in this month's American Journal of Lifestyle Medicine. Researchers found that after a 6-month Weight Watchers group program, overweight or obese adults who attended at least two thirds of the weekly sessions, not only lost weight, but also significantly reduced fasting glucose and insulin levels - important indicators of diabetes risk.
Allergan, Inc. today announced the U.S. Food and Drug Administration's (FDA) approval of JUVÉDERM® XC, a new formulation of the currently FDA-approved JUVÉDERM® dermal filler and the latest advancement in hyaluronic acid (HA) dermal fillers.
Many misconceptions exist about the risks associated with radiation doses and CT scans. Experts at Mayo Clinic want patients to have the right information about radiation dose, including when to have procedures with radiation, such as a CT scan, versus when to have magnetic resonance imaging or other non-radiation tests.
Life Technologies Corporation and the Ignite Institute for Individualized Health announced today a collaboration to create a ground-breaking genomic sequencing center at Ignite's new facility in Northern Virginia.
› Verified 9 days ago